11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Apob-100 Peptide Immunization Reduce Macrophage Plaque Infiltration In Apobec1-/- Ldlr-/- Mice With Advanced Atherosclerotic Lesions
(
- Contribution to journal › Published meeting abstract
-
Mark
Structural And Functional Features Of HDL From Carriers Of The R37X Mutation In CETP Gene
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.236-236(
- Contribution to journal › Published meeting abstract
-
Mark
Expression Of Apolipoprotein M In Fetal Liver: Impact Of Maternal Diabetes
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.714-714(
- Contribution to journal › Published meeting abstract
-
Mark
Low Serum Levels Of DHEA Predict Death From Cardiovascular Disease In Older Men
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.268-268(
- Contribution to journal › Published meeting abstract
-
Mark
Recombinant Apolipoprotein M Secretion Stimulated By HDL
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.1175-1175(
- Contribution to journal › Published meeting abstract
-
Mark
Associations Between Human Leukocyte Antigen (HLA) Genotype And Acute Myocardial Infarction
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.953-953(
- Contribution to journal › Published meeting abstract
- 2006
-
Mark
Atherogenic effects of upper respiratory infections and passive smoking in children with type 1 diabetes mellitus
2006) 14th Meeting of the International Society of Atherosclerosis In Atherosclerosis Supplements 7(3). p.351-351(
- Contribution to journal › Published meeting abstract
- 2005
-
Mark
Association between IGM against an aldehyde-modified peptide sequence in apo B-100 and progression of carotid disease
(
- Contribution to journal › Published meeting abstract
- 2004
-
Mark
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis
(
- Contribution to journal › Published meeting abstract